Biotech Articles Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame Keywords More filters Fewer filters Done October 14, 2026 7:50 AM ETQuantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets BuiltBridget BennettNASDAQ:QNTMNYSE:TMORead Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets BuiltOctober 10, 2026 8:35 AM ET3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts AheadJessica MitacekNASDAQ:IVANASDAQ:LRMRNASDAQ:AAPGRead 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts AheadOctober 8, 2026 7:55 AM ETOnly 20 Stocks Are Holding Up the Market: 3 Bargains Outside AIBridget BennettNYSE:JOBYNASDAQ:CASYNYSE:LLYRead Only 20 Stocks Are Holding Up the Market: 3 Bargains Outside AIOctober 5, 2026 8:55 AM ET3 Small-Cap Stocks With Catalysts That Could Put Them in the SpotlightNathan ReiffNASDAQ:AAPGNASDAQ:MAZENASDAQ:PGYRead 3 Small-Cap Stocks With Catalysts That Could Put Them in the SpotlightOctober 2, 2026 6:00 AM ETInhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech SetupJeffrey Neal JohnsonNASDAQ:INBXRead Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech SetupSeptember 30, 2026 10:45 AM ET3 Emerging Biotech Stocks With Significant Upside PotentialThomas HughesNASDAQ:DCTHNASDAQ:VKTXNASDAQ:AXGNRead 3 Emerging Biotech Stocks With Significant Upside PotentialSeptember 30, 2026 9:35 AM ET3 Healthcare Dividend Stocks Offering More Than Just IncomeChris MarkochNYSE:JNJNYSE:MRKNYSE:ABBVRead 3 Healthcare Dividend Stocks Offering More Than Just IncomeSeptember 28, 2026 9:30 AM ET3 Healthcare Stocks Showing Why the Sector Still Has MomentumNathan ReiffNYSE:OSCRNYSE:HNGENASDAQ:INSMRead 3 Healthcare Stocks Showing Why the Sector Still Has MomentumSeptember 23, 2026 11:20 AM ETViking's Obesity Edge May Be Staying Power, Not Weight LossChris MarkochNASDAQ:VKTXNYSE:LLYNYSE:NVORead Viking's Obesity Edge May Be Staying Power, Not Weight LossSeptember 23, 2026 7:15 AM ETEli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?Thomas HughesNYSE:NVONYSE:LLYRead Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?September 21, 2026 7:45 AM ETThink Outside the Box With These 3 Companies That Make Unusual Business Models WorkNathan ReiffNASDAQ:FLGTNYSE:JOBYNASDAQ:VERIRead Think Outside the Box With These 3 Companies That Make Unusual Business Models WorkSeptember 13, 2026 8:50 AM ET3 Small-Cap Biotechs With Binary Catalysts on the CalendarChris MarkochNASDAQ:KODNASDAQ:IVVDNASDAQ:CAPRRead 3 Small-Cap Biotechs With Binary Catalysts on the CalendarSeptember 11, 2026 10:05 AM ETAmgen Drops 10% on a Trial It Didn't Even RunChris MarkochNASDAQ:AMGNRead Amgen Drops 10% on a Trial It Didn't Even RunSeptember 7, 2026 9:35 AM ETThese 3 Risky Stocks Could Be Sitting on 100% UpsideNathan ReiffNASDAQ:RCATNASDAQ:TSHANYSEAMERICAN:SLSRRead These 3 Risky Stocks Could Be Sitting on 100% UpsideSeptember 6, 2026 6:50 AM ETModerna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItBridget BennettNASDAQ:MRNANYSE:ABTNYSE:ABBVRead Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItSeptember 4, 2026 11:15 AM ETRevolution Medicines Got Its Breakthrough—What Moves It Next?Chris MarkochNASDAQ:RVMDRead Revolution Medicines Got Its Breakthrough—What Moves It Next?September 2, 2026 9:00 AM ETLilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond ObesityChris MarkochNYSE:LLYRead Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond ObesityAugust 29, 2026 7:30 AM ETVenture Into High-Volatility Corners of the Market With These 3 ETFsNathan ReiffNYSEARCA:BBCNYSEARCA:IWCNYSEARCA:GDXJRead Venture Into High-Volatility Corners of the Market With These 3 ETFsAugust 27, 2026 6:35 AM ETWhen Unusual Volume Isn't Noise: 3 Small-Caps Sending SignalsChris MarkochNYSE:GOOSNASDAQ:CCECNASDAQ:SOPHRead When Unusual Volume Isn't Noise: 3 Small-Caps Sending SignalsAugust 22, 2026 9:10 AM ET2 Biotech Stocks Shaping Up for Major BreakoutsRyan HassonNYSE:LLYNASDAQ:NTRARead 2 Biotech Stocks Shaping Up for Major BreakoutsAugust 21, 2026 5:20 AM ETModerna’s 177% Surge Has Investors Asking What Comes NextSam QuirkeNASDAQ:MRNARead Moderna’s 177% Surge Has Investors Asking What Comes NextJuly 27, 2026 7:55 AM ETInnovative ETF Strategies That Are Paying Off This SummerNathan ReiffNYSEARCA:BBCNASDAQ:FMEDNYSE:VRead Innovative ETF Strategies That Are Paying Off This Summer More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
